{"id":"https://openalex.org/W6912370032","doi":"https://doi.org/10.5281/zenodo.15073999","title":"Pharmacological Management of Neurodegenerative Disorders: Current and Future Approaches","display_name":"Pharmacological Management of Neurodegenerative Disorders: Current and Future Approaches","publication_year":2025,"publication_date":"2025-03-24","ids":{"openalex":"https://openalex.org/W6912370032","doi":"https://doi.org/10.5281/zenodo.15073999"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.15073999","doi":"https://doi.org/10.5281/zenodo.15073999","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.15073999","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.15073999","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Mukund Pache*, Hrutuja Kedar, Snehal Kond, Pratik Jadhav, Tejashree R. Kedar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mukund Pache*, Hrutuja Kedar, Snehal Kond, Pratik Jadhav, Tejashree R. Kedar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0968,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.80658676,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9262999892234802,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9262999892234802,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neurological Disorders and Treatments","score":0.025599999353289604,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.9829999804496765},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.859000027179718},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9739999771118164},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":1.0},{"id":"https://openalex.org/keywords/huntington-s-disease","display_name":"Huntington's disease","score":1.0},{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":1.0},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/blood-brain-barrier-drug-delivery","display_name":"blood-brain barrier drug delivery","score":0.9190000295639038},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.996999979019165},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.9330000281333923},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.9829999804496765},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9750000238418579},{"id":"https://openalex.org/keywords/drug-development-challenges","display_name":"drug development challenges","score":0.7609999775886536},{"id":"https://openalex.org/keywords/artificial-intelligence-in-drug-discovery","display_name":"artificial intelligence in drug discovery","score":0.9049999713897705},{"id":"https://openalex.org/keywords/multi-target-drugs","display_name":"multi-target drugs","score":0.8610000014305115},{"id":"https://openalex.org/keywords/lifestyle-intervention","display_name":"lifestyle intervention","score":0.8899999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7190999984741211},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6079999804496765},{"id":"https://openalex.org/C519536355","wikidata":"https://www.wikidata.org/wiki/Q21021151","display_name":"Repurposing","level":2,"score":0.5110999941825867},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.48260000348091125},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4555000066757202},{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.453000009059906},{"id":"https://openalex.org/C103637391","wikidata":"https://www.wikidata.org/wiki/Q5308921","display_name":"Drug repositioning","level":3,"score":0.4408000111579895},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.43470001220703125},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.43459999561309814},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4275999963283539},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3790000081062317},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.3490000069141388},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.34040001034736633},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.3402999937534332},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.32089999318122864},{"id":"https://openalex.org/C2982889124","wikidata":"https://www.wikidata.org/wiki/Q107439039","display_name":"Disease management","level":4,"score":0.31470000743865967},{"id":"https://openalex.org/C2988170871","wikidata":"https://www.wikidata.org/wiki/Q11000047","display_name":"Healthcare system","level":3,"score":0.3012000024318695},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28839999437332153},{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.2856999933719635},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2824000120162964},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.27810001373291016},{"id":"https://openalex.org/C140608501","wikidata":"https://www.wikidata.org/wiki/Q7318358","display_name":"Review article","level":2,"score":0.2542000114917755},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.2535000145435333}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.15073999","doi":"https://doi.org/10.5281/zenodo.15073999","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.15073999","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.15074000","doi":"https://doi.org/10.5281/zenodo.15074000","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.15074000","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.15073999","doi":"https://doi.org/10.5281/zenodo.15073999","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.15073999","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Neurodegenerative":[0],"disorders":[1,30],"(NDs)":[2],"encompass":[3],"a":[4,41],"range":[5],"of":[6,35,37,75,79,96,123,169,179,190,209,213],"debilitating":[7],"conditions":[8],"characterised":[9],"by":[10],"progressive":[11],"neuronal":[12],"damage,":[13],"including":[14,176],"Alzheimer's":[15],"disease":[16,19,22,65],"(AD),":[17],"Parkinson's":[18],"(PD),":[20],"Huntington's":[21],"(HD),":[23],"and":[24,84,99,120,149,151,166,187,192,218],"amyotrophic":[25],"lateral":[26],"sclerosis":[27],"(ALS).":[28],"These":[29],"significantly":[31],"impact":[32],"the":[33,72,76,114,121,167,177,188,210],"quality":[34],"life":[36],"affected":[38],"individuals,":[39],"placing":[40],"considerable":[42],"burden":[43],"on":[44,57,134,221],"healthcare":[45],"systems":[46,110],"globally.":[47],"Despite":[48],"substantial":[49],"research,":[50],"pharmacological":[51,77,214],"treatment":[52,86,227],"remains":[53],"limited,":[54],"primarily":[55],"focusing":[56],"symptom":[58],"management":[59,78],"rather":[60],"than":[61],"halting":[62],"or":[63],"reversing":[64],"progression.":[66],"This":[67,88,203],"review":[68,204],"aims":[69],"to":[70,200],"explore":[71],"current":[73,91,211],"state":[74],"NDs,":[80],"highlighting":[81],"established":[82],"therapies":[83,146,215],"emerging":[85],"strategies.":[87,153,228],"article":[89],"examines":[90],"drug":[92,108,158,183],"treatments,":[93],"their":[94],"mechanisms":[95],"action,":[97],"limitations,":[98],"ongoing":[100],"advancements":[101],"in":[102,143,147,156,163,182],"therapeutic":[103],"approaches.":[104],"Disease-modifying":[105],"therapies,":[106],"innovative":[107],"delivery":[109],"aimed":[111],"at":[112],"overcoming":[113],"blood-brain":[115],"barrier,":[116],"repurposing":[117],"existing":[118],"drugs,":[119],"role":[122],"personalised":[124],"medicine":[125],"have":[126],"been":[127],"explored.":[128],"A":[129],"particular":[130],"emphasis":[131],"is":[132],"placed":[133],"promising":[135],"agents":[136],"such":[137,160],"as":[138,161,197],"monoclonal":[139],"antibodies":[140],"targeting":[141],"amyloid-beta":[142],"AD,":[144],"gene":[145],"HD":[148],"ALS,":[150],"neuroprotective":[152],"Additionally,":[154],"challenges":[155],"neurodegenerative":[157],"development,":[159],"heterogeneity":[162],"patient":[164],"responses":[165],"complexity":[168],"trial":[170],"designs,":[171],"are":[172,195],"discussed.":[173],"Future":[174],"directions,":[175],"integration":[178],"artificial":[180],"intelligence":[181],"discovery,":[184],"multitarget":[185],"approaches,":[186],"importance":[189],"environmental":[191],"lifestyle":[193],"interventions,":[194],"proposed":[196],"potential":[198],"solutions":[199],"these":[201],"challenges.":[202],"provides":[205],"an":[206],"in-depth":[207],"understanding":[208],"landscape":[212],"for":[216,224],"NDs":[217],"sheds":[219],"light":[220],"future":[222],"avenues":[223],"more":[225],"effective":[226]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2025-10-10T00:00:00"}